MedPath

Ropivacaine versus Ropivacaine plus Dexmedetomidine for intraperitoneal instillation and port-site infiltration for pain relief after laparoscopic hysterectomy

Not Applicable
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/01/030820
Lead Sponsor
H Rabindranath Tagore International Institute of Cardiac Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.Patients who gave written informed consent

2.ASA Physical Status I, II or III

3.Age 35-60 years

4.Elective laparoscopic hysterectomy under general anaesthesia

Exclusion Criteria

Patients who:

1.Refused to sign the consent

2.Had allergic history to any drug

3.Were unable to understand VAS

4.Were drug addicts and psychiatric patients

5.Had genital malignancy

6.Had deep pelvic endometriosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath